When.com Web Search

  1. Ads

    related to: pros and cons of osteoporosis medications for women seniors

Search results

  1. Results From The WOW.Com Content Network
  2. Alendronic acid - Wikipedia

    en.wikipedia.org/wiki/Alendronic_acid

    Alendronic acid, sold under the brand name Fosamax among others, is a bisphosphonate medication used to treat osteoporosis and Paget's disease of bone. [4] It is taken by mouth. [ 4 ] Use is often recommended together with vitamin D , calcium supplementation , and lifestyle changes.

  3. Strontium ranelate - Wikipedia

    en.wikipedia.org/wiki/Strontium_ranelate

    Strontium ranelate, a strontium(II) salt of ranelic acid, is a medication for osteoporosis marketed as Protelos or Protos by Servier. Studies indicate it can also slow the course of osteoarthritis of the knee. [1] The drug is unusual in that it both increases deposition of new bone by osteoblasts and reduces the resorption of bone by ...

  4. Bisphosphonate - Wikipedia

    en.wikipedia.org/wiki/Bisphosphonate

    In large studies, women taking bisphosphonates for osteoporosis have had unusual fractures ("bisphosphonate fractures") in the femur (thigh bone) in the shaft (diaphysis or sub-trochanteric region) of the bone, rather than at the femoral neck, which is the most common site of fracture. However, these fractures are rare (12 in 14,195 women ...

  5. Popular vitamin won’t prevent a fall or fracture in older ...

    www.aol.com/news/popular-vitamin-won-t-prevent...

    Steps that older adults can take to reduce their risk of falls and fractures include getting screened for osteoporosis, especially for women 65 and older, Rao said, and getting regular exercise.

  6. Teriparatide - Wikipedia

    en.wikipedia.org/wiki/Teriparatide

    It is an effective anabolic (promoting bone formation) agent [15] used in the treatment of some forms of osteoporosis. [13] [16] Teriparatide is a recombinant human parathyroid hormone analog (PTH 1-34). [13] It has an identical sequence to the 34 N-terminal amino acids of the 84-amino acid human parathyroid hormone. [13]

  7. Denosumab - Wikipedia

    en.wikipedia.org/wiki/Denosumab

    In December 2024, the CHMP adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Stoboclo, intended for the treatment of osteoporosis in women who have been through menopause, bone loss linked to hormone ablation in men at increased risk of fractures and bone loss associated with long-term ...